Article

Two-year body composition analyses of long-lived GHR null mice.

School of Human and Consumer Sciences, College of Health and Human Services, Ohio University, Athens, OH 45701, USA.
The Journals of Gerontology Series A Biological Sciences and Medical Sciences (Impact Factor: 4.31). 11/2009; 65(1):31-40. DOI: 10.1093/gerona/glp175
Source: PubMed

ABSTRACT Growth hormone receptor gene-disrupted (GHR-/-) mice exhibit increased life span and adipose tissue mass. Although this obese phenotype has been reported extensively for young adult male GHR-/- mice, data for females and for other ages in either gender are lacking. Thus, the purpose of this study was to evaluate body composition longitudinally in both male and female GHR-/- mice. Results show that GHR-/- mice have a greater percent fat mass with no significant difference in absolute fat mass throughout life. Lean mass shows an opposite trend with percent lean mass not significantly different between genotypes but absolute mass reduced in GHR-/- mice. Differences in body composition are more pronounced in male than in female mice, and both genders of GHR-/- mice show specific enlargement of the subcutaneous adipose depot. Along with previously published data, these results suggest a consistent and intriguing protective effect of excess fat mass in the subcutaneous region.

0 Bookmarks
 · 
137 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Reduced growth hormone (GH) and insulin-like growth factor 1 (IGF-1) levels have been associated with improved glucose metabolism and increased longevity despite obesity in multiple mouse lines. However, one mouse line, the growth hormone receptor antagonist (GHA) transgenic mouse, defies this trend as it has reduced GH action and increased adiposity but glucose metabolism and lifespan are similar to controls. Slight differences in glucose metabolism and adiposity profiles can become exaggerated on a high fat (HF) diet. Thus, in this study, male and female GHA and WT mice in a C57Bl/6 background were placed on HF and low fat (LF) diets for 11 weeks starting at 10 weeks of age to assess how GHA mice respond to additional metabolic stress of HF-feeding. On a HF diet, all mice showed significant weight gain although GHA gained weight more dramatically than WT mice with males gaining more than females. Most of this weight gain was due to an increase in fat mass with WT mice increasing primarily in the white adipose tissue (WAT) perigonadal depots while GHA mice gained in both the subcutaneous and perigonadal WAT regions. Notably, GHA mice were somewhat protected from detrimental glucose metabolism changes on a HF diet as they had only modest increases in serum glucose levels, remained glucose tolerant and did not develop hyperinsulinemia. Sex differences were observed in many measures with males reacting more dramatically to both a reduction in GH action and HF diet. In conclusion, our findings show that GHA mice, which are already obese, are susceptible to further adipose tissue expansion with HF-feeding while remaining resilient to alterations in glucose homeostasis.
    Endocrinology 11/2014; DOI:10.1210/en.2014-1617 · 4.72 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: In addition to their extended lifespans, slow-aging growth hormone receptor/binding protein gene-disrupted (knockout) (GHR-KO) mice are hypoinsulinemic and highly sensitive to the action of insulin. It has been proposed that this insulin sensitivity is important for their longevity and increased healthspan. We tested whether this insulin sensitivity of the GHR-KO mouse is necessary for its retarded aging by abrogating that sensitivity with a transgenic alteration that improves development and secretory function of pancreatic β-cells by expressing Igf-1 under the rat insulin promoter 1 (RIP::IGF-1). The RIP::IGF-1 transgene increased circulating insulin content in GHR-KO mice, and thusly fully normalized their insulin sensitivity, without affecting the proliferation of any non-β-cell cell types. Multiple (nonsurvivorship) longevity-associated physiological and endocrinological characteristics of these mice (namely beneficial blood glucose regulatory control, altered metabolism, and preservation of memory capabilities) were partially or completely normalized, thus supporting the causal role of insulin sensitivity for the decelerated senescence of GHR-KO mice. We conclude that a delayed onset and/or decreased pace of aging can be hormonally regulated.
    Aging cell 09/2014; DOI:10.1111/acel.12262 · 7.55 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Growth hormone (GH) is important in metabolic control and mice with disruption of the gene encoding the GH receptor (GHR) and GH binding protein (GHR-/- mice) are dwarf with low serum IGF-I and insulin levels, high GH levels and increased longevity despite their obesity and altered lipid and metabolic profiles. Secondary complications of high fat diet (HFD)-induced obesity are reported to be associated with hypothalamic inflammation and gliosis. As GH and IGF-I can modulate inflammatory processes, our objective was to evaluate the effect of HFD on hypothalamic inflammation/gliosis in the absence of GH signaling and determine how this correlates with changes in systemic metabolism. On normal chow GHR-/- mice had a higher percentage of fat mass and increased circulating NEFA levels compared to wild type (WT) and this was associated with increased hypothalamic TNFα and pJNK levels. After seven weeks on a HFD, both WT and GHR-/- mice had increased weight gain with GHR-/- mice having a greater rise in their percentage of body fat. In WT mice HFD-induced weight gain was associated with increased hypothalamic levels of pJNK and the microglial marker Iba1, but decreased cytokine production. Moreover, in GHR-/- mice the HFD decreased hypothalamic inflammatory markers to WT levels with no indication of gliosis. Thus, the GH/IGF-I axis is important in determining not only adipose tissue accrual, but also the inflammatory response to HFD. However, how hypothalamic inflammation/gliosis is defined will determine whether it can be considered a common feature of HFD-induced obesity.
    Endocrinology 09/2014; 155(12):en20141367. DOI:10.1210/en.2014-1367 · 4.72 Impact Factor

Full-text (2 Sources)

Download
10 Downloads
Available from
Sep 9, 2014